ADC Therapeutics (ADCT) Inventory (2021 - 2026)

ADC Therapeutics has disclosed Inventory across 6 years of filings, most recently posting $4.8 million for Q1 2026.

• Inventory for Q1 2026 came in at $4.8 million, down 72.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 million (down 72.63% YoY), and the FY2025 annual result was $4.2 million, up 85.87% from the prior year.
• Inventory came in at $4.8 million for Q1 2026 at ADC Therapeutics, up from $4.2 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $18.0 million in Q3 2025 to a low of $2.3 million in Q4 2024.
• The 5-year median for Inventory is $16.0 million (2024), against an average of $12.7 million.
• Across the five-year window, Inventory sank 86.09% in 2024 and surged 85.87% in 2025, its largest moves.
• ADC Therapeutics' Inventory stood at $12.1 million in 2022, then jumped by 33.99% to $16.2 million in 2023, then sank by 86.09% to $2.3 million in 2024, then jumped by 85.87% to $4.2 million in 2025, then climbed by 14.15% to $4.8 million in 2026.
• The last three Inventory figures came in at $4.8 million (Q1 2026), $4.2 million (Q4 2025), and $18.0 million (Q3 2025), per Business Quant data.